Clinical Trial Update: Bronchiectasis Alpha-1 Augmentation Trial- Modulating Airway Neutrophil Function [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating alpha-1 augmentation to modulate airway neutrophil function in adults with bronchiectasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiectasis

Drugs mentioned

• Alpha-1 augmentation therapy

Snippet

Sponsor: University of Dundee | Conditions: Bronchiectasis Adult | Phase 4 | Status: COMPLETED